drugset / Trial / NCT01426373

Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area

NCT01426373

Phase 3 Completed 165 enrolled Kythera Biopharmaceuticals
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the safety of deoxycholic acid subcutaneous injections in the submental area (below the chin).

Timeline

Start
2011-08
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Deoxycholic Acid Small molecule 2 unknown Subcutaneous

Indications

No indication recorded.